Indication

2008

2012

n

%

n

%

Across indication

all

3149

100.0

2734

100.0

Patients with SRWA

1718

54.6

1429

52.3

and WMR

253

8.0

1095

40.1

no WMR

1465

46.5

334

12.2

Patients without SRWA

1431

45.4

1305

47.7

and WMR

135

4.3

712

26.0

Patients with WMR

388

12.3

1807

66.1

Patients with CM

0

0.0

553

20.2

Musculoskeletal Disorders

all

1521

100

1575

100

Patients with SRWA

833

54.8

888

56.4

and WMR

253

16.6

726

46.1

no WMR

580

38.1

162

10.3

Patients without SRWA

688

45,2

45.2

43.6

and WMR

135

8.9

285

18.1

Patients with WMR

388

25.5

1011

64.2

Patients with CM

0

0.0

343

21.8

Cardiovascular Diseases

all

467

100.0

199

100.0

Patients with SRWA

229

49.0

70

35.2

and WMR

0

0.0

36

18.1

no WMR

229

49.0

30

15.1

Patients without SRWA

238

51.0

129

64,8

and WMR

0

0.0

34

17.1

Patients with WMR

0

0.0

66

33.2

Patients with CM

0

0.0

17

8.5

Cancer

all

398

100.0

255

100.0

Patients with SRWA

283

71.1

174

68.2

and WMR

0

0.0

38

14.9

no WMR

283

71.1

136

53.3

Patients without SRWA

115

28.9

81

31.8

and WMR

0

0.0

5

2.0

Patients with WMR

0

0.0

43

16.9

Patients with CM

0

0.0

12

4.7

Psychosomatic Disorders

all

763

100.0

705

100.0

Patients with SRWA

373

48.9

297

42.1

and WMR

0

0.0

295

41.8

no WMR

373

48.9

2

0.3

Patients without SRWA

390

51.1

408

57.9

and WMR

0

0.0

392

55.6

Patients with WMR

0

0.0

687

97.4

Patients with CM

0

0.0

181

25.7